annual working capital:
$275.14M+$115.29M(+72.12%)Summary
- As of today (July 1, 2025), SLNO annual working capital is $275.14 million, with the most recent change of +$115.29 million (+72.12%) on December 31, 2024.
- During the last 3 years, SLNO annual working capital has risen by +$260.73 million (+1808.72%).
- SLNO annual working capital is now at all-time high.
Performance
SLNO Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$293.18M+$18.04M(+6.56%)Summary
- As of today (July 1, 2025), SLNO quarterly working capital is $293.18 million, with the most recent change of +$18.04 million (+6.56%) on March 31, 2025.
- Over the past year, SLNO quarterly working capital has increased by +$155.43 million (+112.82%).
- SLNO quarterly working capital is now at all-time high.
Performance
SLNO quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
SLNO Working capital Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +72.1% | +112.8% |
3 y3 years | +1808.7% | +1193.5% |
5 y5 years | +1600.5% | +3409.1% |
SLNO Working capital Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | +3201.4% | at high | >+9999.0% |
5 y | 5-year | at high | +3201.4% | at high | >+9999.0% |
alltime | all time | at high | +2274.2% | at high | +2239.4% |
SLNO Working capital History
Date | Annual | Quarterly |
---|---|---|
Mar 2025 | - | $293.18M(+6.6%) |
Dec 2024 | $275.14M(+72.1%) | $275.14M(+13.1%) |
Sep 2024 | - | $243.24M(-5.9%) |
Jun 2024 | - | $258.35M(+87.5%) |
Mar 2024 | - | $137.76M(-13.8%) |
Dec 2023 | $159.85M(+1818.1%) | $159.85M(+548.1%) |
Sep 2023 | - | $24.67M(+110.8%) |
Jun 2023 | - | $11.70M(+756.5%) |
Mar 2023 | - | $1.37M(-83.6%) |
Dec 2022 | $8.33M(-42.2%) | $8.33M(-37.0%) |
Sep 2022 | - | $13.23M(-25.0%) |
Jun 2022 | - | $17.64M(-22.2%) |
Mar 2022 | - | $22.66M(+57.2%) |
Dec 2021 | $14.41M(-65.4%) | $14.41M(-27.4%) |
Sep 2021 | - | $19.84M(-24.2%) |
Jun 2021 | - | $26.18M(-20.7%) |
Mar 2021 | - | $33.02M(-20.7%) |
Dec 2020 | $41.63M(+157.3%) | $41.63M(-14.2%) |
Sep 2020 | - | $48.49M(-11.3%) |
Jun 2020 | - | $54.64M(+554.0%) |
Mar 2020 | - | $8.36M(-48.4%) |
Dec 2019 | $16.18M | $16.18M(+98.4%) |
Sep 2019 | - | $8.15M(-40.7%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2019 | - | $13.76M(-26.1%) |
Mar 2019 | - | $18.61M(-18.3%) |
Dec 2018 | $22.79M(+40.2%) | $22.79M(+156.0%) |
Sep 2018 | - | $8.90M(-21.7%) |
Jun 2018 | - | $11.37M(-18.0%) |
Mar 2018 | - | $13.87M(-14.7%) |
Dec 2017 | $16.26M(+676.6%) | $16.26M(+249.0%) |
Sep 2017 | - | $4.66M(-43.2%) |
Jun 2017 | - | $8.20M(-14.9%) |
Mar 2017 | - | $9.63M(+359.8%) |
Dec 2016 | $2.09M(-34.8%) | $2.09M(-55.7%) |
Sep 2016 | - | $4.73M(+155.0%) |
Jun 2016 | - | $1.85M(-62.9%) |
Mar 2016 | - | $5.00M(+55.8%) |
Dec 2015 | $3.21M(-54.4%) | $3.21M(-739.8%) |
Sep 2015 | - | -$502.00K(-90.3%) |
Jun 2015 | - | -$5.18M(-157.8%) |
Mar 2015 | - | $8.96M(+27.2%) |
Dec 2014 | $7.05M(-155.7%) | $7.05M(-646.8%) |
Sep 2014 | - | -$1.29M(-389.3%) |
Jun 2014 | - | $445.60K(-103.3%) |
Mar 2014 | - | -$13.70M(+8.3%) |
Dec 2013 | -$12.65M(+38.2%) | -$12.65M |
Dec 2012 | -$9.15M | - |
FAQ
- What is Soleno Therapeutics annual working capital?
- What is the all time high annual working capital for Soleno Therapeutics?
- What is Soleno Therapeutics annual working capital year-on-year change?
- What is Soleno Therapeutics quarterly working capital?
- What is the all time high quarterly working capital for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly working capital year-on-year change?
What is Soleno Therapeutics annual working capital?
The current annual working capital of SLNO is $275.14M
What is the all time high annual working capital for Soleno Therapeutics?
Soleno Therapeutics all-time high annual working capital is $275.14M
What is Soleno Therapeutics annual working capital year-on-year change?
Over the past year, SLNO annual working capital has changed by +$115.29M (+72.12%)
What is Soleno Therapeutics quarterly working capital?
The current quarterly working capital of SLNO is $293.18M
What is the all time high quarterly working capital for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly working capital is $293.18M
What is Soleno Therapeutics quarterly working capital year-on-year change?
Over the past year, SLNO quarterly working capital has changed by +$155.43M (+112.82%)